IMM 1.23% 40.0¢ immutep limited

Ann: Immutep hosts Key Opinion Leader Call, page-23

  1. 769 Posts.
    lightbulb Created with Sketch. 70
    "They will discuss their clinical experience with eftilagimod alpha in AIPAC (metastatic breast cancer)"

    It could've of just being me and that it was 5am, and I will have to listen to it again, but they didn't really speak much to the AIPAC stuff at all.....

    I thought it lacked substance...
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
-0.005(1.23%)
Mkt cap ! $581.0M
Open High Low Value Volume
41.0¢ 41.5¢ 39.5¢ $1.576M 3.906M

Buyers (Bids)

No. Vol. Price($)
1 2506 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 8079 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.